*|MC:SUBJECT|*
BioRN News July 2022
View this email in your browser

Dear *|FNAME|* *|LNAME|*,


here for you before the summer-break, a collection of latest news about our network. Maybe something to read during your well-deserved relaxing evenings?

For BioRN, the countdown to the Annual Conference already started. It will take place just few weeks after the break on October 7 in Heidelberg with the title: Molecular Mechanism of Ageing & Longevity >>.
Since 2009, each year the BioRN Annual Conference has been a valuable source of top information, lively discussions and networking opportunities with international experts from different fields of the life sciences. Scientists all over the world are developing technologies to prevent and possibly reverse aging as a root cause of all age-related disorders including Alzheimer’s disease, dementia, cardiovascular diseases, diabetes and cancer. This year we present current trends in research and technology leading to an increase in healthy life span, by unraveling molecular mechanisms of ageing.

KEYNOTEs:
Carien Niessen, Scientific Coordinator CECAD and Head of Cell Biology of the Skin Department, University Hospital Cologne at the University of Cologne
Peter Walter, SVP & Institute Director, Altos Labs - Bay Area Institute of Science and Distinguished Professor Emeritus, University of California, San Francisco Department of Biochemistry & Biophysics

Together with the plenary session we will have an "Exhibit & Pitch Area", a "Young Investigators Pitch Competition" and our brilliant speed-networking with happy hour. Join us and register here.

Enjoy the summer!
 
Annalisa Zuccotti
Events & Communication Lead
BioRN Life Science Cluster Rhine-Neckar
01 | Research Highlights & News
02 | New BioRN Members
03 | BioRN Annual Conference
04 | Event Calendar & Discounts
05 | Open Positions
01| Research Highlights & News

Translational bridge partnership beLAB2122 selects oncology project from Goethe University Frankfurt [more]

AION Labs, in continued partnership with BioMed X, launches fourth global call for application: Prediction of clinical trial outcome in cancer patient populations [more]

DKFZ: RNA modifications in mitochondria promote invasive spread of cancer [more]

EMBL Researchers develop approach to leverage the function of an elusive small satellite DNA molecule and to harness its immune defence powers [more]

Evotec, Boehringer Ingelheim, and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance [more]

With "KMU-innovativ: Biomedicine", the BMBF is strengthening the innovative power of SMEs in medical biotechnology [more]

Heidelberg Pharma and Chiome Bioscience sign exclusive, target specific research and option agreement for the development of an Antibody Drug Conjugate [more]

Human gut microbiome disease prediction: Advancing disease prevention with NEC MicrobiomePredict  [more]

Construction modules float in: Next new building on the hip to be completed by the end of the year - Heidelberg Technology Park and BioLabs as users. [more]

With the support of the University of Heidelberg, AAvigen is working on a platform technology to introduce therapeutic genes into diseased heart muscle cells. [more]

Ymmunobio signs collaboration agreement with YUMAB to optimize its antibody development [more]
 

02 | New BioRN Members

ariadne.ai ag is a contract research organization (CRO) for automated high-throughput biomedical image analysis and cuttingedge image processing technology - scalable in throughput and consistent in quality. The company accelerates research and development efforts by solving image processing and analysis bottlenecks. The interdisciplinary team of scientists and machine-learning experts at ariadne.ai combines human and artificial intelligence to turn terabytes of imaging data into quantitative results.
Founded in 1897 in the Swiss Alps, today, Lonza operates across five continents. Lonza is a preferred global partner to the pharmaceutical, biotech and nutrition markets, enabling a healthier world by supporting customers to deliver new and innovative medicines that help treat a wide range of diseases. This is achieved by combining technological insight with world-class manufacturing, scientific expertise and process excellence.

03 | BioRN Annual Conference


Molecular Mechanism of Ageing & Longevity
Oct 7, 2022


Scientists all over the world are developing technologies to prevent and possibly reverse aging as a root cause of all age-related disorders including Alzheimer’s disease, dementia, cardiovascular diseases, diabetes and cancer.
This year Annual Conference presents current trends in research and technology leading to an increase in healthy life span, by unraveling molecular mechanisms of ageing.
  • KEYNOTE: Carien Niessen, Scientific Coordinator CECAD and Head of Cell Biology of the Skin Department, University Hospital Cologne at the University of Cologne
  • KEYNOTE: Peter Walter, SVP & Institute Director, Altos Labs - Bay Area Institute of Science and Distinguished Professor Emeritus, University of California, San Francisco Department of Biochemistry & Biophysics
  • Jan Adams, Apollo Health Ventures
  • Jürgen Bauer, Heidelberg University, Agaplesion Bethanien Hospital
  • Judith Zaugg, EMBL and part of Molecular Medicine Partnership Unit (MMPU) Stem Cell Niche Network

04 | Event Calendar & Discounts

Bioinformatic Analysis of Single Cell Data
Introduction to bioinformatic analysis of scRNA-seq data
August 1, 2022 - Online >>

 
Bioinformatic Analysis of Single Cell Data
Pre-processing of scRNA-seq data
August 8, 2022 - Online >>

 
Bioanalytical Tools for Biosimilar Development
August 10, 2022 - Online >>
 
Bioinformatic Analysis of Single Cell Data
Downstream analysis of scRNA-seq data – Basics
August 15, 2022 - Online >>

 
Enabling innovation within the MedTech industry - Apply today for Meet&Match.Dx programme
August 16, 2022 - Online >>
 
Arzneimittelzulassung für Einsteiger, Seminar 2 (Live Online Seminar) /Forum Institut für Management
August 25, 2022 - Online >>
 
Biotechgate Digital Partnering
August 29 - September 2, 2022 - Online
Premium Upgrade for free for members >>

 
Connect in Pharma 2022
September 14 - 15, 2022 - Geneva >>
 
Start Up BW - Summit 2022
September 30, 2022 - Stuttgart >>
 
„StartupTrifftMittelstand“
October 11, 2022 - on-line >>
 
BIO-Europe
October 24-26, 2022 - Leipzig
10% off for members >>

 
BioFIT Event
Discount for BioRN Members
November 29-30,2022 - Strasbourg, France >>

 

05 | Open Positions


AION Labs, in partnership with BioMed X Call for Application: Prediction of Clinical Trial Outcome in Biomarker-Stratified Cancer Patient Populations [more]


GSK-Cellzome:  Strategy, Operations, and Alliances Manager (m/f/d) [more]

Heidelberg AI Health Innovation Cluster:
  • 14 Interdisciplinary Postdoc Positions [more]
  • Up to 19 Staff Scientist Positions [more]

HITS:  Medical Data Specialist, Medical Informatics Scientist or Bioinformatician (m/f/d) [more]

Innovationscampus Health & Life Sciences:  Wissenschaftliche:n Koordinator:in (w/m/d) [more]

Johnson & Johnson:  Director Early Innovation Partnering (m/f/d) Pharm, Germany (Rhein-Kreis Neuss) [more]

PROGEN:
  • Technischer Mitarbeiter in der Forschung und Entwicklung (m/w/d) [more]
  • Marketing Kommunikations Assistent (m/w/d) [more]
WMTherapeutics:
  • Cell & Molecular Biology intern [more]
  • Medicinal Chemistry intern [more]
In today’s competitive environment, the gene to First In Human (FIH) journey is complicated and more challenging than ever.
Expert Advice at Your Fingertips
Through a series of webinars, renowned experts drawn from both inside Lonza and a wide network of innovative biotech companies, will outline fundamental building blocks and provide invaluable insights needed for success.
To access your webinar series register today. >>
 
Tweet
Forward
Share

Imprint


Copyright © *|CURRENT_YEAR|* *|LIST:COMPANY|*, All rights reserved.
*|IFNOT:ARCHIVE_PAGE|* *|LIST:DESCRIPTION|*

Responsible for the content:
Dr. Julia Schaft

Editor: Dr. Annalisa Zuccotti

Our mailing address is:
*|HTML:LIST_ADDRESS_HTML|* *|END:IF|*

Commercial Register: Mannheim, HRB 704801
VAT ID: DE 2630 64 014

unsubscribe from this list    update subscription preferences 

*|IF:REWARDS|* *|HTML:REWARDS|* *|END:IF|*